Clinical Trials Browser

Has results × Neoplasm Metastasis × Gefitinib × Clear all

NCT01774721 2023-11-14

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Phase 3 Completed

452 enrolled 35 charts 1 FDA

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00344773 2010-06-29

First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 2 Completed

46 enrolled 7 charts

Lung Neoplasms, Neoplasm Metastasis